COMMUNIQUÉS West-GlobeNewswire

SPINEWAY : Mise en place du nouveau plan stratégique signature d'un contrat de financement
10/07/2018
Mise en place du nouveau plan stratégique Signature d'un contrat de financement avec Alpha Blue Ocean par émission réservée d'OCEANE assorties de BSA Conformément à l'annonce du 13 juin 2018, SPINEWAY, spécialiste des [...]
Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver
10/07/2018
The agreement aims to develop and market software solutions to aid physicians' in their treatment recommendations and follow-up care for liver cancer. Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am [...]
Guerbet et IBM Watson Health annoncent un partenariat stratégique alliant l'intelligence artificielle à l'imagerie médicale
10/07/2018
L'accord vise à développer et commercialiser une solution logicielle d'aide au diagnostic et au suivi dans le cancer du foie. Villepinte (France) et Cambridge (Etats-Unis) - le 10 juillet 2018 (8:30 CEST) - Guerbet, [...]
Shire plc : Rule 2.9 announcement
10/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 10 July 2018 Shire [...]
MediciNova Announces Clinical Data from Subgroup Analyses of Completed Clinical Trial of MN-166 (ibudilast) in ALS
10/07/2018
LA JOLLA, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]
Mesa Labs Declares Quarterly Dividend
10/07/2018
Lakewood, Colorado, July 09, 2018 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of [...]
Helix BioPharma Corp. Closes Private Placement
09/07/2018
RICHMOND HILL, Ontario, July 09, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Adamas Announces New Employment Inducement Grant
09/07/2018
EMERYVILLE, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the compensation committee of the company’s board of directors granted two new employees the option [...]
TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History
09/07/2018
Ribociclib Combination Therapy in Adjuvant Setting Represents A Promising Therapy Against Breast Cancer EDMONTON, Alberta, July 09, 2018 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today announced a [...]
Actinium to Host Webcast on July 10, 2018 to Discuss Actimab-A MRD clinical trial for Minimal Residual Disease in Postremission AML Patients
09/07/2018
Minimal Residual Disease is increasingly recognized as a primary driver of high AML relapse with a need for improved consolidation therapies Webcast to be held on July 10, 2018 at 8:00 AM ET to discuss planned trial [...]
T2 Biosystems Reports Granting of Inducement Awards
09/07/2018
LEXINGTON, Mass., July 09, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]
Spero Therapeutics Announces Proposed Offering of Common Stock
09/07/2018
CAMBRIDGE, Mass., July 09, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel [...]
Inspire Medical Systems, Inc. Announces Aetna Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea
09/07/2018
MINNEAPOLIS, July 09, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
TLC Reports Last Patient Last Visit (LPLV) in TLC599 Phase II Trial and FDA Clearance to Commence New Clinical Trials
09/07/2018
LPLV marks the final steps toward completion of TLC599 trial for osteoarthritis (OA) pain Phase II topline results on-track for 2018 release Set to initiate enrollment of US Phase II pharmacokinetic (PK) trial for [...]
EnviroLogix Introduces QuickScan II
09/07/2018
EnviroLogix Inc.'s history as a technology innovator for the global agricultural diagnostic markets continues with the introduction of the next generation QuickScan II instrument for quantitative GMO and mycotoxin [...]
Sanofi: Disclosure of trading in own shares
09/07/2018
Attachment Disclosure of trading in own shares (pdf).pdf
Sanofi : Déclaration des transactions sur actions propres
09/07/2018
Pièce jointe Déclaration des transactions sur actions propres (pdf).pdf
Ossur Hf : Transactions in relation to share buyback program
09/07/2018
Announcement no. 43/2018 Reykjavik, 09 July 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
OncBioMune’s Phase 2 Clinical Trial of ProscaVax for Early-Stage Prostate Cancer is Now Included on ClinicalTrials.gov
09/07/2018
BATON ROUGE, La., July 09, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Pages